Lambert-Eaton Can Develop From Cancer Therapy Opdivo, Case Report Says
Lambert-Eaton myasthenic syndrome (LEMS) can develop as an immune-related adverse event caused by treatment with the anti-cancer therapy Opdivo (nivolumab), according to a case report. The study describes the case of a 73-year-old Japanese woman who started to…